HEMATOLOGICAL MALIGNANCIES
Clinical trials for HEMATOLOGICAL MALIGNANCIES explained in plain language.
Never miss a new study
Get alerted when new HEMATOLOGICAL MALIGNANCIES trials appear
Sign up with your email to follow new studies for HEMATOLOGICAL MALIGNANCIES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
MRNA shot takes on Hard-to-Treat blood cancers
Disease control Not yet recruitingThis early study tests a new medicine called WGb-0302 for people with blood cancers like multiple myeloma that have returned or not responded to other treatments. The drug uses mRNA technology (similar to some COVID-19 vaccines) to help the body attack cancer cells. About 20 adul…
Matched conditions: HEMATOLOGICAL MALIGNANCIES
Phase: EARLY_PHASE1 • Sponsor: Sichuan University • Aim: Disease control
Last updated May 17, 2026 06:48 UTC
-
Injection instead of lab: new CAR-T therapy could transform blood cancer care
Disease control Not yet recruitingThis early-phase study tests a new type of CAR-T therapy that is given as an injection, instead of the usual process of removing and modifying cells in a lab. It targets a protein called CD20 found on certain blood cancer cells. The goal is to see if this approach is safe and eff…
Matched conditions: HEMATOLOGICAL MALIGNANCIES
Phase: EARLY_PHASE1 • Sponsor: The 923rd Hospital of Joint Logistics Support Force of People's Liberation Army • Aim: Disease control
Last updated May 15, 2026 11:54 UTC
-
Supercharged immune cells target hard-to-treat blood cancers
Disease control Not yet recruitingThis study tests a new treatment for people with aggressive T-cell blood cancers (like T-cell lymphoma or leukemia) that are in first remission. The treatment uses specially engineered natural killer (NK) cells from donated cord blood, designed to target and destroy cancer cells.…
Matched conditions: HEMATOLOGICAL MALIGNANCIES
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 14, 2026 12:03 UTC
-
New stem cell graft technique aims to reduce transplant complications in blood cancer patients
Disease control Not yet recruitingThis study tests a new way to prepare stem cell grafts from half-matched donors for adults with high-risk blood cancers who lack a fully matched donor. The approach removes certain immune cells to lower the risk of severe graft-versus-host disease, a common and serious complicati…
Matched conditions: HEMATOLOGICAL MALIGNANCIES
Phase: NA • Sponsor: Miltenyi Biomedicine GmbH • Aim: Disease control
Last updated May 11, 2026 20:47 UTC
-
French blood cancer Patients' secret remedies revealed
Knowledge-focused Not yet recruitingThis study looks at how people with blood cancers in France use complementary therapies like acupuncture, herbs, or meditation alongside standard treatment. Researchers will survey 85 patients and interview some to understand why they use these methods and how it affects their we…
Matched conditions: HEMATOLOGICAL MALIGNANCIES
Phase: NA • Sponsor: University Hospital, Limoges • Aim: Knowledge-focused
Last updated May 17, 2026 06:46 UTC